Pharmaceutical Serialization Rapidly Expands Hologram Adoption
Pharmaceutical manufacturers increasingly specify serialization-integrated holograms previously limited to a handful of pilot regulatory-compliance programs, applying documented origination-complexity and traceability engineering across an expanding list of mid-size regional drug manufacturers as regulatory expectations increasingly make documented serialization a measurable procurement attribute rather than a manageable security detail. This shift is creating substantial new demand beyond the category's traditional currency base, giving serialization-capable originators a genuine growth avenue tied to specification-driven adoption rather than pure basic-foil volume growth. Originators with established pharmaceutical relationships are capturing disproportionate share of this expanding demand worldwide.
Market Impact: Sustains 31% of category volume








